BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meijer B, Mulder CJ, van Bodegraven AA, de Boer NKH. How I treat my inflammatory bowel disease-patients with thiopurines? World J Gastrointest Pharmacol Ther 2016; 7(4): 524-530 [PMID: 27867685 DOI: 10.4292/wjgpt.v7.i4.524]
URL: https://www.wjgnet.com/1007-9327/full/v7/i4/524.htm
Number Citing Articles
1
Hong-Hui Wang, Ying He, Hong-Xian Wang, Cheng-Ling Liao, Yu Peng, Li-Jian Tao, Wei Zhang, Hui-Xiang Yang. Comparison of <i>TPMT</i> and <i>NUDT15</i> polymorphisms in Chinese patients with inflammatory bowel diseaseWorld Journal of Gastroenterology 2018; 24(8): 941-948 doi: 10.3748/wjg.v24.i8.941
2
Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel diseaseExpert Opinion on Drug Metabolism & Toxicology 2021; 17(12): 1433 doi: 10.1080/17425255.2021.2029406
3
Femke Crouwel, Hans J. C. Buiter, Nanne K. de Boer. Discontinuation rate of azathioprineLiver International 2020; 40(12): 3141 doi: 10.1111/liv.14574
4
Debbie S. Deben, Rob H. Creemers, Arjan J. van Adrichem, Roosmarie Drent, Audrey H. H. Merry, Mathie P. G. Leers, Adriaan A. van Bodegraven, Dennis R. Wong. A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patientsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-20197-5
5
Wenyu Jiang, Shasha Wu, Meijiao Lu, Jiahui Tian, Xiufang Cui, Xiaqiong Mao, Chunhua Jiao, Nana Tang, Jingjing Ma, Hongjie Zhang, Keiko Hosohata. NUDT15 Haplotypes and Diplotypes Predict Thiopurine-Induced Leukopenia and the Influence of Prolonged Exposure to Azathioprine on Hematologic Indices in Patients with Inflammatory Bowel DiseasesJournal of Clinical Pharmacy and Therapeutics 2023; 2023: 1 doi: 10.1155/2023/3000409
6
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
7
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters, Nanne K. De Boer. The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive reviewExpert Opinion on Drug Metabolism & Toxicology 2020; : 1 doi: 10.1080/17425255.2020.1719996
8
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828